Catechin Containing Mask for the Prevention of Influenza Infection
The Effects of Tea Catechin Extracts Containing Mask on the Prevention of Influenza Infection
2 other identifiers
interventional
180
1 country
2
Brief Summary
The purpose of this study is to evaluate the effects of catechin extracts containing mask on prevention of influenza infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2008
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 18, 2008
CompletedFirst Posted
Study publicly available on registry
December 22, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedNovember 26, 2009
November 1, 2009
11 months
December 18, 2008
November 24, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the incidence rate of influenza infection during the study
assessed at each month
Secondary Outcomes (3)
the incidence rates of upper respiratory tract infections
assessed at each month
the severity of the symptoms and the duration of the cold among incident cases
assessed at each month
he incidence-free time for influenza or upper respiratory tract infections after the intervention
assessed at each month
Study Arms (1)
tea catechin extracts containing mask
EXPERIMENTALwearing the tea catechin extracts containing mask
Interventions
catechins are composed of tea catechin extracts available in grren tea supplements
Eligibility Criteria
You may qualify if:
- Possible to wearing mask for three months
- Possible to fill out a questionnaire personally
- Obtained written informed consent before participation
You may not qualify if:
- Possessing some infectious diseases in need of therapy
- Possessing tea or catechin allergy
- diagnosed as inadequate for other reasons to participate the study by principal investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Shizuokalead
- Seirei Hamamatsu General Hospitalcollaborator
- Hamamatsu Universitycollaborator
Study Sites (2)
Seirei Hamamatsu General Hospital
Hamamatsu, Shizuoka, Japan
University of Shizuoka
Shizuoka, Shizuoka, 422-8526, Japan
Study Officials
- STUDY CHAIR
Hiroshi Yamada, MD,PhD
University of Shizuoka
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 18, 2008
First Posted
December 22, 2008
Study Start
December 1, 2008
Primary Completion
November 1, 2009
Study Completion
November 1, 2009
Last Updated
November 26, 2009
Record last verified: 2009-11